Nancy J. Wysenski
2009
In 2009, Nancy J. Wysenski earned a total compensation of $10.2M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals.
Compensation breakdown
| Bonus | $25,000 |
|---|---|
| Option Awards | $9,295,540 |
| Salary | $31,846 |
| Stock Awards | $793,800 |
| Other | $32,028 |
| Total | $10,178,214 |
Wysenski received $9.3M in option awards, accounting for 91% of the total pay in 2009.
Wysenski also received $25K in bonus, $31.8K in salary, $793.8K in stock awards and $32K in other compensation.
Rankings
In 2009, Nancy J. Wysenski's compensation ranked 212th out of 9,885 executives tracked by ExecPay. In other words, Wysenski earned more than 97.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 212 out of 9,885 | 98th |
Division Manufacturing | 73 out of 3,690 | 98th |
Major group Chemicals And Allied Products | 18 out of 871 | 98th |
Industry group Drugs | 16 out of 643 | 98th |
Industry Pharmaceutical Preparations | 14 out of 446 | 97th |
Source: SEC filing on April 10, 2012.
Wysenski's colleagues
We found six more compensation records of executives who worked with Nancy J. Wysenski at Vertex Pharmaceuticals in 2009.
2009
Matthew Emmens
Vertex Pharmaceuticals
Chief Executive Officer
2009
Joshua Boger
Vertex Pharmaceuticals
Chief Executive Officer
2009
Peter Mueller
Vertex Pharmaceuticals
Chief Scientific Officer
2009
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2009
Amit Sachdev
Vertex Pharmaceuticals
Senior Vice President, Corporate Affairs and Public Policy, and Commercial Business Lead, Canada
2009
Kenneth Boger
Vertex Pharmaceuticals